0001209191-20-030672.txt : 20200519 0001209191-20-030672.hdr.sgml : 20200519 20200519182149 ACCESSION NUMBER: 0001209191-20-030672 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200518 FILED AS OF DATE: 20200519 DATE AS OF CHANGE: 20200519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clark Kenneth A CENTRAL INDEX KEY: 0001561736 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 20895098 MAIL ADDRESS: STREET 1: C/O PHARMACYCLICS, INC. STREET 2: 995 EAST ARQUES AVE. CITY: SUNNYVALE STATE: CA ZIP: 94085 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Biosciences, Inc. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 465696597 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 510-906-4600 MAIL ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-05-18 0 0001625101 Pulse Biosciences, Inc. PLSE 0001561736 Clark Kenneth A 3957 POINT EDEN WAY HAYWARD CA 94545 1 0 0 0 Stock Option (right to buy) 10.66 2020-05-18 4 A 0 20000 0.00 A 2020-06-18 2030-05-18 Common Stock 20000 20000 D Stock Option (right to buy) 10.66 2020-05-18 4 A 0 14071 0.00 A 2020-09-05 2030-05-18 Common Stock 14071 14071 D The shares subject to the option will vest in equal monthly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. The shares subject to the option will vest in equal quarterly installments over a one year period, subject to the Reporting Person's continued service through each vesting date. /s/ Sandra Gardiner, as Attorney-in-Fact 2020-05-19 EX-24 2 attachment1.htm EX-24 DOCUMENT

                                POWER OF ATTORNEY

      The undersigned, as a Section 16 reporting person of PULSE
BIOSCIENCES, INC. (the "Company"), hereby constitutes and appoints
Darrin R. Uecker and Sandra A. Gardiner, and each of them, the
undersigned's true and lawful attorney-in-fact, to:

      1. complete and execute Forms 3, 4 and 5 and other forms and all
amendments thereto as such attorney-in-fact shall in his or her discretion
determine to be required or advisable pursuant to Section 16 of the
Securities Exchange Act of 1934 (as amended) and the rules and regulations
promulgated thereunder, or any successor laws and regulations, as a
consequence of the undersigned's ownership, acquisition or disposition of
securities of the Company; and

      2. do all acts necessary in order to file such forms with the U.S.
Securities and Exchange Commission, any securities exchange or national
association, the Company and such other person or agency as the attorney-
in-fact shall deem appropriate.

      The undersigned hereby ratifies and confirms all that said attorneys-
in-fact and agents shall do or cause to be done by virtue hereof.  The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving
in such capacity at the request of the undersigned, are not assuming, nor
is the Company assuming, any of the undersigned's responsibilities to
comply with Section 16 of the Securities Exchange Act of 1934 (as amended).

      This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms ID, 3, 4 and 5 with respect
to the undersigned's holdings of and transactions in securities issued by
the Company, unless earlier revoked by the undersigned in a signed writing
delivered to the Company and the foregoing attorneys-in-fact.

      IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 12 day of December, 2019.

      					Signature: /s/ Kenneth A. Clark

      					Print Name: Kenneth A. Clark